LncRNA MAGI2‐AS3 plasma levels have been evaluated in patients with IDD pre‐ and post‐treatment, and the findings indicated that patients with IDD were found to exhibit reduced lncRNA MAGI2‐AS3 expression, and its expression was significantly augmented after clinical treatments.15 This evidence concerns the gene MAGI2 and intervertebral disk degenerative disorder.